Company news
Summit Therapeutics Inc. news in 2020
Summit Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.
Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
November 22, 2020
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
November 15, 2020
Summit Announces Closing of Private Placement of $50 Million
November 5, 2020
Summit Announces Agreement For a Fundraising of approximately $50 Million
October 1, 2020
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020
September 28, 2020
Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA
September 17, 2020
Summit Therapeutics Announces U.K. Court Approval of Scheme
September 16, 2020
Summit Announces Results of Court Meeting and General Meeting
August 18, 2020
Summit Announces Intention to Redomicile its Holding Company to the United States
July 15, 2020
Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome Health
July 12, 2020
Summit Appoints Michael Donaldson as Chief Financial Officer
June 7, 2020
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020
June 1, 2020
Summit Therapeutics Reports Financial Results for the Fourth Period and Eleven Months Ended December 31, 2019, and Operational Progress
April 29, 2020
Summit Appoints Robert W. Duggan as Chief Executive Officer
April 13, 2020
Summit Appoints Robert W. Duggan as Executive Chairman
February 25, 2020